Safi Bahcall
Overview
Safi Bahcall is an American physicist, technologist, business executive, and author known for his contributions to the technology and gaming sectors. He has been involved in various ventures, including serving as an angel investor and advisor to several startups. Bahcall's expertise spans multiple industries, reflecting his diverse interests and investments. In addition to his investment activities, Bahcall has a background in physics and business. He co-founded Synta Pharmaceuticals, a biotech company that developed new drugs for cancer, and served as its CEO for 13 years. He has also been involved in various speaking engagements and has authored a book on innovation. Bahcall's investment philosophy emphasizes nurturing innovative ideas and supporting companies that aim to transform industries. His approach combines his scientific background with his business acumen to identify and support ventures with high growth potential.
Investment Focus
- Innovative technology solutions
- Scalable business models
- Experienced management teams
- Clear market differentiation
- Strong intellectual property portfolio
- Potential for significant impact in target industries
- Alignment with Bahcall's investment philosophy
Portfolio Companies
Reach Safi Bahcall directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Safi Bahcall
What sectors does Safi Bahcall invest in?
Safi Bahcall invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Media, and is based in District of Columbia, United States. Safi Bahcall is listed as a angel investor in the ConnectSafely investor database.
What stage does Safi Bahcall invest at?
Safi Bahcall backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Safi Bahcall invest in?
Safi Bahcall invests across United States.
What companies has Safi Bahcall invested in?
Safi Bahcall's portfolio includes Synta Pharmaceuticals, Madrigal Pharmaceuticals and Virgin Galactic Holdings Inc.
Last updated · Source: ConnectSafely investor database
